Company

X-Vax Technology, Inc.

X-Vax Technology, Inc. develops vaccines for infectious diseases, selling them to healthcare providers and public health entities.

About

Founded in 2015 and based in Jupiter, US, X-Vax Technology, Inc. develops vaccine products for infectious disease control, sold to healthcare providers and public health entities, mainly in the US. Its Series A round on July 18, 2019 raised USD 9.78 mn from investors including the Bill & Melinda Gates Foundation and Johnson & Johnson Innovation. The company has completed four deals, with Roger Pomerantz as founder and Ulf Wiinberg as CEO.

2Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in